Effect of Red Grape Cells (RGC) Powder Consumption on Measures of Aerobic Fitness and Mood

July 13, 2014 updated by: Fruitura Bioscience Ltd.

A Double-blind, Randomized, Placebo Controlled Study of the Effect of Red Grape Cells (RGC) Powder Consumption on Measures of Aerobic Fitness, Body Composition and Mood

This is a 3-arm double blind placebo controlled study to investigate the effect of Red Grape Cell (RGC) powder containing all the matrix of polyphenols that can be found in red grapes. polyphenols have several beneficial effects on various body systems, are present in many edible foods, and are considered safe for human consumption by regulatory authorities. Animal and human studies suggest a potential for polyphenol-rich compounds in enhancing mitochondrial activity and exercise capacity. However, the effect of RGC on exercise performance in humans had not yet been tested. A special population where increasing performance is highly sought are competitive athletes. The aim of the current study is to investigate the effect of RGC on measures of aerobic fitness, body composition and mood in trained male cyclists

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tel-Hashomer, Israel, 52621
        • Sheba Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Age 18 - 65 years, men only
  • Active in cycling training group
  • Willingness to avoid regular use of NSAIDS (Advil, Nurofen, etc.) and aspirin for the entire study period
  • Without a history or evidence of significant cardiovascular, hepatic, renal, respiratory, hematopoietic, gastrointestinal disease, endocrine, metabolic, psychiatric or psychological disorders;
  • Willingness to avoid regular ingestion of any foods containing peanuts, bilberries, blueberries, cranberries, strawberries, raspberries, grapes, grape juice, cocoa powder, dark chocolate, red wine, over-the-counter medications, herbs, or supplements throughout the entire study, and to record and report any occasional consumption of such substances

Exclusion Criteria:

  • Any acute medical situation (e.g., acute infection, nausea and vomiting, diarrhea) 48 hours prior to initiation of the study, which is considered of significance by the principal investigator.
  • Any known chronic medical condition (will be determined by the principal investigator)
  • History or evidence of alcohol or drug abuse
  • Any gastrointestinal surgery other than appendectomy or herniotomy;
  • Current use of over the counter or prescription weight loss medication
  • Current use or within the last 30 days, any cholesterol lowering medications (statins, fibrates, red yeast rice, niacin).
  • Known allergy to casein and/or soy.
  • Subjects who had participated in a drug trial 3 months before initiation of the study;
  • Non-cooperative subjects or unwilling to sign an informed consent and participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: RGC1
200 mg of Red Grape Cell (RGC) powder; daily oral dose
Other Names:
  • Red Grape Cell powder
Experimental: RGC2
1000 mg of Red Grape Cell (RGC) powder; daily oral dose
Other Names:
  • Red Grape Cell powder
Placebo Comparator: Placebo
1000 mg placebo to Red Grape Cell (RGC) powder; daily oral dose

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
changes in aerobic fitness
Time Frame: baseline and 6 weeks
baseline and 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Body Mass Index (BMI)
Time Frame: baseline and 6 weeks
baseline and 6 weeks
Changes in mood
Time Frame: baseline and 6 weeks
baseline and 6 weeks
Changes in body weight
Time Frame: baseline and 6 weeks
baseline and 6 weeks
Changes in body composition
Time Frame: baseline and 6 weeks
changes in body fat percentage
baseline and 6 weeks

Other Outcome Measures

Outcome Measure
Time Frame
Number of adverse events
Time Frame: 6 weeks
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gal Dubnov-Raz, M.D, Sheba Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (Actual)

September 1, 2013

Study Completion (Actual)

September 1, 2013

Study Registration Dates

First Submitted

April 11, 2013

First Submitted That Met QC Criteria

April 12, 2013

First Posted (Estimate)

April 16, 2013

Study Record Updates

Last Update Posted (Estimate)

July 15, 2014

Last Update Submitted That Met QC Criteria

July 13, 2014

Last Verified

July 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • RGC-04

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Placebo

Subscribe